Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enlivex Therapeutics Ltd

ENLV
Current price
1.76 USD 0 USD (0.00%)
Last closed 1.72 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 33 477 480 USD
Yield for 12 month -58.83 %
Week
Month
Year
ENLV
21.11.2021 - 28.11.2021

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ENLV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -26 049 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -28.18 %
PEG Ratio
Return On Equity TTM -53.23 %
Wall Street Target Price 12 USD
Revenue TTM
Book Value 2.09 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.47 USD
Diluted Eps TTM -1.47 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ENLV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ENLV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:8
Payout Ratio
Last Split Date 06.03.2019
Dividend Date 06.03.2019

Stock Valuation ENLV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.2879
Price Book MRQ 0.8633

Financials ENLV

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ENLV

For 52 weeks

1.27 USD 4.65 USD
50 Day MA 1.58 USD
Shares Short Prior Month 118 394
200 Day MA 2.52 USD
Short Ratio 2.88
Shares Short 111 104
Short Percent 0.64 %